Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Comparison of Antibodies with Amylase Activity from Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.
The Role of Medicinal Cannabis in Clinical Therapy: Pharmacists' Perspectives.
Papers: 10 Jan 2016 - 17 Jan 2016
Papers: 5 Oct 2015 - 12 Oct 2015
Manual Segmentation of MS Cortical Lesions Using MRI: A Comparison of 3 MRI Reading Protocols.
Rebound Syndrome in Patients With Multiple Sclerosis After Cessation of Fingolimod Treatment.
Papers: 26 Jun 2015 - 3 Jul 2015
Resilience Despite Relapse
Papers: 26 Sep 2015 - 3 Oct 2015
Papers: 13 Nov 2015 - 20 Nov 2015
Papers: 15 Jan 2016 - 22 Jan 2016
Multiple Sclerosis: Diagnostic and Treatment Frontiers
Papers: 28 Feb 2016 - 6 Mar 2016
Papers: 10 Oct 2015 - 17 Oct 2015
Multiple sclerosis disease-modifying therapy and pregnancy.
Papers: 5 Mar 2016 - 12 Mar 2016
Papers: 28 Mar 2016 - 4 Apr 2016
Resisting Arrest
Episode 80 with Dr. Kaarina Kowalec on adverse MS drug reactions
Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis.
The Characteristics of Multiple Sclerosis in Iran.
Papers: 27 Dec 2015 - 3 Jan 2016
The Long-Term Value of Glatiramer Acetate for the Treatment of Relapsing Remitting Multiple Sclerosis in the Netherlands.
Regional Frontal Perfusion Deficits in Relapsing-Remitting Multiple Sclerosis with Cognitive Decline.
The molecular basis of nutritional intervention in multiple sclerosis: a narrative review.
Pages
« first
‹ previous
…
26
27
28
29
30
31
32
33
34
…
next ›
last »
